Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials
Authors
Keywords
Cancer cachexia, Weight loss, Sarcopenia, Systemic inflammation, Anamorelin
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-11-27
DOI
10.1186/s12885-018-5080-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers
- (2018) Bizhan Kouchaki et al. SUPPORTIVE CARE IN CANCER
- The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial
- (2018) Jenny G. Turcott et al. SUPPORTIVE CARE IN CANCER
- Comparison of Three Different Treatment Modalities in the Management of Cancer Cachexia
- (2018) Ozkan Kanat et al. TUMORI
- Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
- (2018) Tora S Solheim et al. BMJ Supportive & Palliative Care
- Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis
- (2017) Kenichi Nishie et al. LUNG CANCER
- Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis
- (2017) Yu Bai et al. SUPPORTIVE CARE IN CANCER
- Anamorelin hydrochloride in the treatment of cancer anorexia–cachexia syndrome: design, development, and potential place in therapy
- (2017) Solomon Graf et al. Drug Design Development and Therapy
- Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways
- (2017) Guohua Zhang et al. Scientific Reports
- Research priorities in cancer cachexia
- (2017) Richard F. Dunne et al. Current Opinion in Supportive and Palliative Care
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials
- (2016) Eric J. Roeland et al. SUPPORTIVE CARE IN CANCER
- Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
- (2016) Koichi Takayama et al. SUPPORTIVE CARE IN CANCER
- Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials
- (2015) José M Garcia et al. LANCET ONCOLOGY
- Effects of Melatonin on Appetite and Other Symptoms in Patients With Advanced Cancer and Cachexia: A Double-Blind Placebo-Controlled Trial
- (2013) Egidio Del Fabbro et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia
- (2012) Katsutoshi Ando et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study
- (2012) Sriram Yennurajalingam et al. JOURNAL OF PALLIATIVE MEDICINE
- Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
- (2011) Clelia Madeddu et al. CLINICAL NUTRITION
- C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting
- (2011) Guohua Zhang et al. EMBO JOURNAL
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
- (2011) James T. Dalton et al. Journal of Cachexia Sarcopenia and Muscle
- Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting
- (2010) Norleena P Gullett et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways
- (2010) Alexander Doyle et al. FASEB JOURNAL
- Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia
- (2010) G. Mantovani et al. ONCOLOGIST
- Medroxyprogesterone acetate in the management of cancer cachexia
- (2009) Clelia Madeddu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Nonsteroidal selective androgen receptor modulator Ostarine™in cancer cachexia
- (2009) Mihail F Zilbermint et al. Future Oncology
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- Marine phospholipids—a promising new dietary approach to tumor-associated weight loss
- (2009) Lenka A. Taylor et al. SUPPORTIVE CARE IN CANCER
- An update on promising agents for the treatment of cancer cachexia
- (2009) Clelia Madeddu et al. Current Opinion in Supportive and Palliative Care
- Cachexia, survival and the acute phase response
- (2008) Nathan A Stephens et al. Current Opinion in Supportive and Palliative Care
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now